# Henrietta Lacks *The archive holds Henrietta Lacks as a foundational author of modern biomedicine whose tissue was taken, named, and monetised while she was erased as a thinker and a patient.* > Black's Encyclopedia — the sourced record of Black American life. > Portal: Science & Invention · Status: In review · Revised: July 24, 2026 · Revisions: 1 > Canonical: https://www.blacksencyclopedia.com/record/henrietta-lacks-3245 ## Questions this record answers - Who really made HeLa cells possible? - What did Henrietta Lacks build in modern medicine? - How did the medical system use Henrietta Lacks without her consent? - Why is the story of HeLa cells usually told without Henrietta Lacks’ full life and family history? ## Summary Henrietta Lacks, a Black tobacco farmer and mother from Baltimore by way of rural Virginia, is the patient whose living cervical cancer cells became HeLa, the first immortal human cell line and the backbone of much of twentieth- and twenty-first-century biomedicine. She built, through her body and unwanted participation in research, the experimental base that underlies the polio vaccine, cancer therapies, virology, space medicine, and innumerable lab protocols, even as hospitals, laboratories, and companies named the cells while they omitted her name, her consent, and her family from the record. Her story is not only a tale of exploitation but also of foundational authorship: without her cells, whole lines of inquiry would have taken different paths or far longer to establish. The archive presents Lacks not as a passive victim but as an uncredited originator whose biological contribution shaped global medicine and whose descendants have fought to assert that authorship. ## The archive's standing The archive holds Henrietta Lacks as one of the central builders of modern experimental medicine, a woman whose cells powered an entire scientific era and whose life story exposes how Black patients and families have been written out of the systems they made possible. Her stature lies not only in the biological fact of HeLa cells but in the political and ethical reckoning her case forced: global institutions had to confront consent, compensation, and recognition because her family demanded that they do so. We treat Lacks as an author of medical infrastructure, not merely as a subject of it, and we read the secrecy around her case as evidence of how much her contribution mattered. The archive does not accept the naming of a cell line as adequate credit; it insists on the woman, her community, and their ongoing claim on what was built from her body. ## Origins and the Making of HeLa Henrietta Lacks (born Loretta Pleasant in Roanoke, Virginia, 1920) migrated within the Jim Crow South and later to Turner Station, a Black working-class community outside Baltimore, as part of the wartime movement of Black labor to industrial centers. In January 1951 she entered Johns Hopkins Hospital—the only major Baltimore institution that treated Black patients at the time—for abdominal pain and abnormal bleeding, where physicians diagnosed an aggressive cervical carcinoma. During her treatment, samples of her tumor and healthy cervical tissue were taken without her informed consent, a common practice in an era when poor and Black patients were seen as clinical material rather than partners in care. Those tumor cells were passed to Dr. George Gey’s tissue culture lab, where technicians observed that unlike other samples that died after a few divisions, Lacks’s cancer cells divided rapidly and indefinitely under the right conditions. Lab staff designated them “HeLa,” a label derived from the first two letters of her first and last names, both obscuring her identity and fixing her tissue as a generic research tool. Lacks herself was never told that her cells were being cultured and distributed worldwide. She continued to undergo painful radium treatments, cared for her children, and remained embedded in the Black social and religious life of Turner Station until her death on October 4, 1951, at age 31. The medical record preserved measurements and slides but not the fullness of her relationships, labor, and spiritual life, reflecting the broader pattern of how Black women’s experiences were compressed into clinical categories. ## What HeLa Built HeLa cells rapidly became a global platform for experimentation. Their ability to survive, proliferate, and be shipped made them the first robust human cell line used at scale, enabling standardized tests of viruses, drugs, radiation, and environmental toxins. Within a few years, HeLa cells were central to Jonas Salk’s and others’ efforts to test and refine the polio vaccine, allowing researchers to grow poliovirus and assay vaccine effectiveness without constant reliance on live animals. Beyond polio, HeLa cells were used to develop chemotherapies, to understand the mechanics of cancer cell division, to map chromosomes, and to study the effects of microgravity in early space missions. They were instrumental in virology, including work on measles, mumps, and later HIV, and became a reference line for countless basic biology experiments, from membrane transport to gene expression. Laboratories around the world purchased or received HeLa batches, built protocols around them, and treated them as a kind of invisible infrastructure of modern science. In this archive’s framing, these achievements are not abstract “advances” but concrete structures built from Lacks’s cellular labor: each HeLa-derived protocol is part of the edifice she enabled. The invisibility of her name in most lab notes and publications is not evidence that she was incidental; it is the mark of a system that normalized the extraction of Black bodily material while granting authorship and profit to those already empowered. ## Erasure, Family Testimony, and the Black Archive For decades, Lacks’s family knew nothing about HeLa. The cells traveled through white-dominated academic and corporate networks while her relatives in Turner Station and Clover, Virginia, struggled with poverty, unequal healthcare, and the ordinary work of survival. It was only in the 1970s, when researchers approached her children for blood samples in an effort to sort out contamination among cell lines, that the family learned fragments of the story—told in technical language and without acknowledgment of the ethical breach. Black oral history and church records preserve a different narrative: Lacks as a vibrant woman, stylish, social, deeply involved in her family’s life. Family testimonies describe her as someone who “took care of everybody,” a description that resonates with the way her cells were literally made to care for everyone else’s medical needs without her being asked. These testimonies are evidence in their own right; they correct the clinical picture and restore her as an agent in her own story. When journalist Rebecca Skloot began interviewing Lacks’s children and community in the 1990s, she drew heavily on this Black archive—family recollections, photographs, funeral programs, and local memory—to reconstruct the life behind HeLa. The resulting book, and later the film adaptation, made Lacks’s name known to millions but also sparked debates about who controls that story and who benefits from it. The Lacks family’s insistence on being co-authors of their mother’s legacy, and on negotiating with institutions like the National Institutes of Health over data access, marks a shift from pure extraction to contested ownership. ## Policy, Profit, and the Question of Authorship HeLa cells were commercialized through the sale of culture kits and lab supplies, generating revenue for companies and expanding research capacity for universities and government agencies. None of this profit flowed to Lacks or her descendants, and for decades there was little legal recognition that patients whose tissues became valuable might have claims to control or share in that value. Court decisions on tissue ownership tended to favor institutions, framing discarded bodily material as something patients had relinquished once removed. The archive reads this legal framing as part of a broader disability imposed on Black authorship: Black and poor patients were structurally barred from being recognized as co-creators of medical knowledge, both by consent doctrines that treated them as objects and by intellectual property systems that recognized scientists and corporations, not subjects, as inventors. In Lacks’s case, the very fact that her cells were anonymized and then mislabeled under pseudonyms for decades shows the system’s awareness that there was a person at the origin—and its determination not to let that person complicate the flow of data and profit. In the 2010s, the Lacks family reached agreements with the NIH over access to HeLa genomic data, including representation on a working group overseeing requests from researchers. This partial recognition does not retroactively make the original extraction consensual, but it does mark an institutional admission that the family’s voice matters in decisions about the use of HeLa. The archive sees this as a small but significant shift toward the presumption of authorship: acknowledging that without Lacks, and without the Black community that sustained her, a major branch of modern science would look different. ## Memory, Monuments, and Continuing Reckonings In recent years, hospitals, universities, and municipalities have erected plaques, named buildings and scholarships, and held ceremonies in Lacks’s honor. While these memorials risk being symbolic substitutes for material redress, they also create public spaces where her story can be taught as part of medical and Black history. Black-led initiatives—family-organized foundations, church programs, and community health workshops—use her case to educate about consent, genetic privacy, and the long history of Black bodily exploitation as a predicate for white scientific prestige. The archive situates these efforts alongside the testimonies preserved in Black newspapers and oral histories, treating them as part of an ongoing authorship: Lacks’s descendants and community are actively rewriting the narrative that once left her nameless. Her case has entered medical ethics curricula and policy debates, making future extractions harder to justify and forcing institutions to confront the human stories behind cell lines and biobanks. We therefore hold Henrietta Lacks not only as a historical figure but as a living force in the governance of science. The struggle over her legacy exemplifies how Black families, churches, and local memory work can reshape official records, reassert authorship over technologies built from their bodies, and demand that the instruments of past theft be turned toward accountability. ## Sources 1. Rebecca Skloot, The Immortal Life of Henrietta Lacks, Crown, 2010. 2. National Institutes of Health, "Points to Consider in the HeLa Genome Data Use Agreement," NIH, 2013. 3. Johns Hopkins University, "The Legacy of Henrietta Lacks," Office of Communications and Public Affairs, 2010. 4. Alondra Nelson, Body and Soul: The Black Panther Party and the Fight Against Medical Discrimination, University of Minnesota Press, 2011 (for broader context on Black communities’ resistance to medical exploitation). ## Related records - https://www.blacksencyclopedia.com/record/hela-cells - https://www.blacksencyclopedia.com/record/tuskegee-syphilis-study - https://www.blacksencyclopedia.com/record/black-participation-in-medical-research - https://www.blacksencyclopedia.com/record/informed-consent-in-human-subjects-research - https://www.blacksencyclopedia.com/record/black-church --- Cite as: Black's Encyclopedia, "Henrietta Lacks," revised July 24, 2026. https://www.blacksencyclopedia.com/record/henrietta-lacks-3245 Text under the Black's Record License: cite the record, keep attribution attached, cite the revision date.